Marker Therapeutics, Inc.

Monthly Archives: May 2019

Marker Therapeutics to Present at Two Upcoming Investor Conferences

Marker Therapeutics will present at and participate in two upcoming investor conferences.
Read More


Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference

President and Chief Executive Officer, Peter L. Hoang, to present at the 2019 Bank of America Merrill Lynch Health Care Conference.
Read More

Non-Engineered T Cells to Prevent or Treat Relapse in Post-Transplant AML/MDS

Non-Engineered T Cells to Prevent or Treat Relapse in Post-Transplant AML/MDS

Read More